These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15207021)

  • 1. Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer.
    Amador ML; Hidalgo M
    Clin Colorectal Cancer; 2004 May; 4(1):51-62. PubMed ID: 15207021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer.
    Snyder LC; Astsaturov I; Weiner LM
    Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S71-80. PubMed ID: 16336752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of small-molecule tyrosine kinase inhibitors targeting epidermal growth factor receptor in colorectal cancer.
    Kuo T; Fisher GA
    Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S62-70. PubMed ID: 16336751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the epidermal growth factor receptor in the treatment of colorectal carcinoma.
    Waxman ES; Herbst RS
    Semin Oncol Nurs; 2002 May; 18(2 Suppl 2):20-9. PubMed ID: 12053861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
    Efferth T
    Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of epidermal growth factor receptor-targeted antibody therapy in previously treated colorectal cancer.
    Watkins D; Cunningham D
    Clin Colorectal Cancer; 2007 Oct; 6 Suppl 2():S47-52. PubMed ID: 18021487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
    Kendall A; Lord R; Maisey N
    Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):142-51. PubMed ID: 19954416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions.
    Starling N; Cunningham D
    Curr Opin Oncol; 2004 Jul; 16(4):385-90. PubMed ID: 15187895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor-targeted therapy in colorectal cancer.
    O'dwyer PJ; Benson AB
    Semin Oncol; 2002 Oct; 29(5 Suppl 14):10-7. PubMed ID: 12422309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives.
    Spano JP; Fagard R; Soria JC; Rixe O; Khayat D; Milano G
    Ann Oncol; 2005 Feb; 16(2):189-94. PubMed ID: 15668269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer.
    De Pauw I; Wouters A; Van den Bossche J; Peeters M; Pauwels P; Deschoolmeester V; Vermorken JB; Lardon F
    Pharmacol Ther; 2016 Oct; 166():71-83. PubMed ID: 27373506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.
    Ruzzo A; Graziano F; Canestrari E; Magnani M
    Curr Cancer Drug Targets; 2010 Feb; 10(1):68-79. PubMed ID: 20088793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor as a target for chemotherapy.
    Vallbohmer D; Lenz HJ
    Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S19-27. PubMed ID: 15871762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting EGFR in pancreatic cancer treatment.
    Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
    Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.
    Tedesco KL; Lockhart AC; Berlin JD
    Curr Treat Options Oncol; 2004 Oct; 5(5):393-403. PubMed ID: 15341677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?
    Ponz-Sarvisé M; Rodríguez J; Viudez A; Chopitea A; Calvo A; García-Foncillas J; Gil-Bazo I
    World J Gastroenterol; 2007 Nov; 13(44):5877-87. PubMed ID: 17990353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidermal growth factor receptor as a target for colorectal cancer therapy.
    Lockhart AC; Berlin JD
    Semin Oncol; 2005 Feb; 32(1):52-60. PubMed ID: 15726506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-targeted therapies in colorectal cancer.
    Overman MJ; Hoff PM
    Dis Colon Rectum; 2007 Aug; 50(8):1259-70. PubMed ID: 17566832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies.
    Zhang W; Gordon M; Lenz HJ
    Ann Med; 2006; 38(8):545-51. PubMed ID: 17438669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.